Please login to the form below

Not currently logged in
Email:
Password:

MHRA operation seizes 20,000 unlicensed sex drugs

The Medicines and Healthcare products Regulatory Agency announced that £50,000 worth of unlicensed sex drugs have been seized in Woking as part of Operation Jaipur
The Medicines and Healthcare products Regulatory Agency (MHRA) announced that £50,000 worth of unlicensed sex drugs have been seized in Woking as part of Operation Jaipur.

Enforcement officers from the MHRA, assisted by Thames Valley Police, took possession of approximately 20,000 units of the unlicensed sex medicines, which included Kamagra tablets and jellies used for male impotence. The drug haul was a direct result of the early morning operation that saw officers search three addresses in the Woking and Bracknell area.

Mick Deats, group manager of enforcement at the MHRA, said the agency is committed to protecting public health and that it is imperative that medicines are licensed correctly.

"The type of medicines we seized cannot be guaranteed to be safe because they have not been assessed for safety, quality and efficacy," said Deats. "At best these medicines could be a waste of money, at worst they could be severely detrimental to your health."

11th July 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics